SNGX

Conviction 4HealthcareScan · Thu, Jun 25, 2026

SNGX$0.4009+2.53%

ResistanceSupportVol 14

Vol MA14 1.89M

Mar 26Apr 14May 1May 19Jun 8Jun 25

SOLIGENIX, INC.PHARMACEUTICAL PREPARATIONSwww.soligenix.com ↗

Price0.4009

Change+2.53%

Gap+0.61%

Rel volume0.03×

Avg volume4.08M

Avg $ vol2.87M

SMA 200.5136

SMA 500.6034

SMA 2001.23

Price vs 50-33.56%

Price vs 200-67.52%

MA stackbearish

50/200 cross—

Supertrenddown · 0.5583

RSI (14)41

MACD hist-0.00

MACD cross—

Stoch %K / %D29 / 16

ADX (14)20

+DI / −DI23 / 31

RSI divergence—

MACD divergence—

ATR %+16.10%

ADR %10.60%

52w high4.96

52w low0.2801

From 52w high-91.92%

Above 52w low+43.13%

New 52w highNo

SqueezeOff

Bollinger width141.25%

%B0.34

Donchian pos4.90%

Donchian high1.00

Donchian low0.3700

AVWAP (52w high)1.92

vs AVWAP high-79.12%

AVWAP (52w low)0.7744

vs AVWAP low-48.23%

OBV trendDown

Chaikin MF (20)-0.10

Today vs 20d0.03×

Avg vol (14d)1.89M

Avg vol (20d)4.08M

Avg $ vol (20d)2.87M

Market cap5.94M

RS 3m (vs SPY)-78.84%

RS 6m (vs SPY)-79.40%

RS line new highNo

Trend template1/8

Technical rank7.2

1 week-0.27%

1 month-21.85%

3 months-66.59%

6 months-69.86%

1 year-69.86%

YTD-71.77%

P/E-0.54

P/B1.92

P/S49.79

P/FCF-0.58

EPS-2.14

Div yield—

ROE-358.60%

ROA-160.06%

Debt/Eq0.00

Current1.81

EV/EBITDA1.43

Gross margin81.52%

Net margin—

Rev growth0.00%

EPS growth-34.04%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-16.93M

Revenue2.34K

Net income-2.82M

Gross profit20K

Free cash flow-10.27M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out14.82M

Employees14

ListedTue, Apr 5, 1994

Free float9.77M

Float %96.9%

Short interest6.51M

Days to cover0.1d

Short volume31.1%

Squeeze score41 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank7.2 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.7900

Support0.3108

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SNGX

All disclosures →

No recent disclosed trades by Congress in SNGX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SNGX

No recent insider (Form 4) filings in SNGX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in SNGX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.